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Malignant melanoma shows high levels of intrinsic drug resistance associated with a highly invasive phenotype.
In this study, we investigated the role of the drug transporter P-glycoprotein (Pgp) in the invasion potential of
drug-sensitive (M14 WT, Pgp-negative) and drug-resistant (M14 ADR, Pgp-positive) human melanoma cells.
Coimmunoprecipitation experiments assessed the association of Pgp with the adhesion molecule CD44 in
multidrug resistant (MDR) melanoma cells, compared with parental ones. In MDR cells, the two proteins
colocalized in the plasma membrane as visualized by confocal microscopy and immunoelectron microscopy on
ultrathin cryosections. MDR melanoma cells displayed a more invasive phenotype compared with parental cells,
as demonstrated by quantitative transwell chamber invasion assay. This was accomplished by a different
migration strategy adopted by resistant cells (‘‘chain collective’’) previously described in tumor cells with high
metastatic capacity. The Pgp molecule, after stimulation with specific antibodies, appeared to cooperate with
CD44, through the activation of ERK1/2 and p38 mitogen-activated protein kinase (MAPK) proteins. This
activation led to an increase of metalloproteinase (MMP-2, MMP-3, and MMP-9) mRNAs, and proteolytic
activities, which are associated with an increased invasive behavior. RNA interference experiments further
demonstrated Pgp involvement in migration and invasion of resistant melanoma cells. A link was identified
between MDR transporter Pgp, and MAPK signaling and invasion.
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INTRODUCTION
Melanoma is a radiation- and chemotherapy-refractory
neoplasm and there is no standard therapy for patients with
disseminated disease. Commonly used anticancer drugs do
not alter the prognosis, which invariably has a fatal outcome.
Patients with advanced diseases, such as lymph node
involvement and distant metastases, have 5-year survival
rates of 50 and 10–20%, respectively (Buzzell and Zitelli,
1996). This poor treatment response, typically observed in
clinical settings, is due to the intrinsic survival features of
their parental melanocytes, nourished by additional altera-
tions gained during tumor progression, and to a sequence of
acquired genetic alterations selected throughout the course of
therapy (Soengas and Lowe, 2003).
Acquired drug resistance includes the classical multidrug
resistance (MDR) phenomenon accompanied by the over-
expression of ATP-binding cassette (ABC) transporters. These
transporters can play key roles in pharmacology, affecting
both the entry of drugs into the cells and their extrusion.
Although there is still debate regarding the resistance of some
tumors, the importance of membrane transporters and
channels, such as the multiple drug resistance transporter
ABCB1 (MDR1, P-glycoprotein, Pgp), has recently been
corroborated (Huang et al., 2004). Clinical pathological
studies and experimental reports indicate an upregulation of
drug pumps such as the Pgp (Berger et al., 1994; Alvarez
et al., 1995; McNamara et al., 1996; Molinari et al., 2000) or
the MDR-associated protein (MRP-1) (Schadendorf et al.,
1995a, b) in resistant melanoma under treatment.
Strikingly, the expression of MDR1 transporter can be
deviously masked, but it is easily inducible by cytotoxic stress
(Molinari et al., 2000).
In the past, studies of drug resistance and invasion/
metastasis generally proceeded along separate pathways of
research. More recently, interest has been focused on the
relationship between the two phenomena, and evidence is
growing rapidly that they can be linked to each other
(reviewed in Liang et al., 2002). Yang et al. (2003) reported
that the extracellular matrix metalloproteinase (MMP)
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inducer EMMRPIN, a cell surface glycoprotein belonging to
the immunoglobulin superfamily and involved in invasion
and metastasis, is overexpressed in MDR cells and not in
drug-sensitive parental cell lines. Moreover, the expression
levels of a panel of metastasis- and drug resistance-related
genes were analyzed in a study carried out on a human
prostate carcinoma cell line (PC-3M) and its variants with
different metastatic ability. Highly metastatic cells growing
in culture expressed higher levels of mRNA for b-FGF,
IL-8, MMP-2, MMP-9, and Pgp than poorly metastatic cells
and parental cells. This suggests a possible correlation
between metastasis and Pgp-mediated drug resistance
(Greene et al., 1997). In addition, drugs transported by Pgp
induced membrane ruffling, which is an early indicator of
cellular motility and metastatic potential, in Pgp overexpres-
sing cancer cells. This effect may be mediated through
activation of phosphatidylinositol 3-kinase (Yang et al.,
2002). As far as melanoma is concerned, Pgp activity
appeared to be associated with less differentiated and more
aggressively metastasizing tumors although its role in
maintaining this phenotype remains to be established
(Witkowski et al., 2000).
The phenotypic alterations associated with the acquisition
of the MDR phenotype were previously investigated in
human melanoma cells. The expression of cell adhesion
molecules was analyzed in a panel of multidrug-resistant
melanoma cell lines (M14 Dx) which showed different
degrees of resistance to doxorubicin and different levels of
the expression of the drug transporter Pgp (Molinari et al.,
2002). A progressive downregulation of CD44 expression on
plasma membrane was revealed in M14 Dx cells, in parallel
with an increasing level of Pgp.
CD44, the major cell surface receptor to hyaluronan, has
been implicated in cell adhesion, metastasis, and tumor
progression (Birch et al., 1991; Bartolazzi et al., 1994; Ponta
et al., 2003). CD44 overexpression in melanoma cells
enhances their experimental metastatic potential and tumor-
igenicity (Birch et al., 1991) but its clinical significance in
cutaneous melanoma is still unclear. A clinical pathological
study reported that reduced cell surface CD44 expression
enhances the spreading potential in localized cutaneous
melanoma (Karjalainen et al., 2000). The CD44 protein
family participates in many cellular processes, which include
the regulation of growth, survival, and differentiation, other
than motility. CD44 proteins assemble intracellular com-
plexes that are important in signal transduction: key players
in this regulation are ezrin, radixin, and moesin (ERM)
proteins. In the phosphorylated form, ERM proteins anchor
CD44 to actin and support cell proliferation (reviewed in
Ponta et al., 2003).
The association of Pgp with actin mediated by ERM family
proteins was also demonstrated in drug-resistant human
tumor cells. Such an association appeared to be essential for
maintaining of the MDR phenotype (Luciani et al., 2002). The
interactions between the plasma membrane and cytoskeleton
play an essential role in cell signaling (Tsukita et al., 1997),
cell adhesion (Mangeat et al., 1999), motility (del Pozo et al.,
1996), and apoptosis (Parlato et al., 2000).
Recent experimental data indicate that a relationship
between CD44 and the MDR1 transporter Pgp does exist in
carcinoma cell lines (Miletti-Gonza´lez et al., 2005). In this
study, it was stated that the expression of Pgp alone does not
increase the migration potential and that it is the interaction
of Pgp with CD44 that affects cell migration.
In a preliminary study on the invasive properties of
multidrug-resistant cells, we found that in drug-selected
human melanoma cells, the overexpression of the drug
transporter Pgp was associated with an increase of migration
and invasive potential. In addition, an interaction of Pgp and
CD44 in conferring this more invasive phenotype was
suggested (Molinari et al., 2005).
Thus, the purpose of this study was to clarify the role of
Pgp in the invasive potential of melanoma cells by employing
drug-sensitive (M14 WT, Pgp-negative) and drug-resistant
(M14 ADR, Pgp-positive) cells. The transwell chamber
invasion assay, a modification of the Boyden chamber
chemotaxis assay (Albini et al., 1987) with reconstituted
membrane (MatrigelTM), was employed. This in vitro assay
allows a rapid quantification of the relative invasive potential
of metastatic cells, and it was found to correspond to
metastatic potential in vivo within a wide variety of cell
systems (Albini et al., 2004).
We found that the overexpression of Pgp was associated
with a more invasive phenotype of melanoma cells, mediated
by the association and molecular vicinity between Pgp and
CD44.
RESULTS
Pgp and CD44 expression
The analysis of the expression of the MDR transporter Pgp
and of the adhesion molecule CD44 was performed on both
human melanoma drug-sensitive (M14 WT) and -resistant
(M14 ADR) cells.
M14 ADR-resistant variants expressed a high level of the
drug transporter Pgp, when compared to their drug-sensitive
parental counterparts. In particular, M14 WT cells expressed
Pgp only in the cytoplasmic membranes of the Golgi
apparatus (Molinari et al., 1998). The in vitro selection, by
continuous exposure to the antitumoral drug doxorubicin,
induced an increased expression of the MDR transporter,
as revealed by RT-PCR, flow cytometry, and Western
blot analysis (Calcabrini et al., 2004). Fluorescence laser
scanning confocal microscopy (LSCM) observations demons-
trated that a large amount of the drug transporter was
localized on the cell surface. Figure 1 shows the three-
dimensional reconstruction of optical sections of wild-type
(Figure 1a) and resistant (Figure 1b) melanoma cells, labeled
with the mAb MM4.17 which recognizes an extracellular
epitope of the Pgp molecule (Cianfriglia et al., 1994). Both
sensitive and resistant M14 cells were also analyzed for the
expression of the CD44 adhesion molecule. M14 WT and
M14 ADR cells displayed an almost similar level of CD44
expression (Figure 1c and d). LSCM observations were in
agreement with findings obtained by Western blotting
analysis performed on lysates from M14 WT and M14 ADR
cells (Figure 2).
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Pgp-CD44 colocalization and coimmunoprecipitation
Double-labeling experiments by LSCM performed on both
M14 WT (Figure 3a–c) and M14 ADR cells (Figure 3d–i)
demonstrated that CD44 and Pgp colocalized in some
regions of the plasma membrane of M14 ADR cells.
M14 WT cells labeled with mAb against CD44, revealed
by an anti-mouse IgG (TRITC, red), displayed the adhesion
molecule localized on the plasma membrane. Only a weak
signal coming from intracytoplasmic Pgp (FITC, green) was
detected (Figure 3b, arrow).
In Figure 3d, a three-dimensional reconstruction of
optical-sectioned double-labeled M14 ADR cells is reported.
The analysis of optical sections demonstrated that the
adhesion molecule (FITC, green) and the drug transporter
(TRITC, red) colocalized preferentially on ruffles (green-
red¼ yellow colored) of resistant cells (Figure 3e, arrow-
heads). The two molecules were also visible in small vesicles
at the cell surface level (Figure 3f, arrowheads). As observed
in sequential optical sections (Figure 3g–i), carried out from
the basal-cell surface (bottom) to the apical cell surface (top)
of the sample, intracytoplasmic yellow spots (arrowheads)
were also detected in the proximity of the plasma membrane.
LSCM data strongly suggested that Pgp and CD44
molecules shared the same shuttle vesicles to be transported
toward the plasma membrane. Thus, the intracellular
transport of CD44 and Pgp was investigated by double
immunolabeling on cryosections. Sequential labeling of Pgp
and CD44 molecules, performed with anti-Pgp mAb MM4.17
and anti-CD44 mAb F4, followed by anti-mouse IgG
conjugates with 5 and 10 nm gold particles, showed that
the two molecules were transported from the inner layer of
the cell to the plasma membrane by different vesicles
(Figure 4). When vesicles positive for Pgp (5 nm gold) and
CD44 (10 nm gold) were in the proximity of the plasma
membrane (Figure 4a–c) they began to coalesce. At the
surface level, complexes of 5 and 10 nm gold particles were
frequently observed (Figure 4d): this finding suggested that
Pgp and CD44 molecules together reached the cell surface.
Interestingly, vesicles positive for both molecules were also
visible outside the cells (Figure 4d, arrow), suggesting that
Pgp and CD44 were released by the cells. Similar results were
also obtained while performing the double labeling by
inverted sequence (CD44 and Pgp, data not shown).
Coimmunoprecipitation experiments were performed
using cell lysates from sensitive and resistant cells to assess
the level of Pgp association with the CD44 molecule. mAb
against Pgp (JSB1) recognized a band at 170 kDa in
immunoprecipitates of CD44 obtained from M14 ADR
lysates, but not in those obtained from parental line cells
(Figure 5a). Anti-CD44 mAb F4 recognized a band at 90 kDa
in immunoprecipitates of Pgp (Figure 5b). Anti-Pgp mAb
MM4.17 immunoprecipitates a little amount of intracyto-
plasmic Pgp expressed in M14 WT, as demonstrated
previously (Molinari et al., 1998). On the other hand, Pgp
and CD44 were colocalized in intracytoplasmic vesicles as
described above. Specific control antibodies (mouse IgG2a
and IgG1) immunoprecipitated neither CD44 nor Pgp.
Adhesion, motility, and invasion assays
The adhesion assay (Table 1) indicated that resistant M14
ADR cells showed similar adhesion properties to different
substrates when compared to their sensitive counterparts.
However, both sensitive and resistant cells generally
demonstrated a greater capability of adhering to fibronectin
when compared to the other substrates, being fibronectin4
collagen4matrigel4hyaluronan4control.
Drug-sensitive and -resistant melanoma cells were also
analyzed for their migration and invasion potential by using
Figure 1. Expression of Pgp and CD44 proteins in M14 WT and M14 ADR
cells. LSCM observations on (a and c) drug-sensitive (M14 WT) and (b and d)
drug-resistant (M14 ADR) cells, labeled with (a and b) anti-Pgp (MM4.17)
and (c and d) anti-CD44 (F4) mAbs, respectively. In contrast to (a) M14 WT
cells, (b) the resistant variants showed a high expression of the multidrug
transporter Pgp on the cell surface. In contrast, the major receptor for
hyaluronan, CD44, was equally expressed on the plasma membrane of both
(c) sensitive and (d) resistant M14 cells. Bar¼ 50mm.
90 kDa
55 kDa
CD44 (F4)Pgp (JSB1)
170 kDa
Tubulin
WT ADR ADRWT
Figure 2. Expression of Pgp and CD44 in M14 WT and M14 ADR cells by
western blotting. Membranes were incubated with specific antibodies to
Pgp (JSB1) and CD44 (HCAM). Immunoreactive bands were visualized by the
ECL kit. For loading control, membranes were incubated with monoclonal
anti-a-tubulin.
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the ‘‘transwell chamber invasion assay’’, modified by Albini
et al. (1987). In particular, the in vitro motile and invasive
activities of M14 WT and M14 ADR cells across the filters,
coated with MatrigelTM (invasion) or not (motility), were
investigated. The qualitative and quantitative analysis of
migration and invasion processes was carried out by scanning
electron microscopy (SEM) and computer-assisted light
microscopy, respectively.
As confirmed by the quantitative analysis data (see below),
M14 ADR cells displayed a migration potential higher than
their parental counterparts. In fact, SEM analysis showed
that, 24 hours after seeding into the inserts, M14 ADR cells
(Figure 6b) were more numerous below the filter when
compared with M14 WT cells (Figure 6a). This demonstrated
a rate of crossing the filter higher than their parental
counterparts. During the initial phase of the transfer, 3 hours
after seeding, sensitive melanoma cells displayed morpho-
logic features typical of the cellular migration (Figure 6c and d).
The trailing edge of the cell, visible on the upper side of the
filter, displayed a high concentration of blebs, with remaining
focal contacts still not disassembled (Figure 6c, arrow). In the
lower side of the filter, the migrating front characterized by
pseudopodi (Figure 6d, arrow), numerous blebs (Figure 6d,
double arrowheads), lamellipodi (Figure 6d, asterisk), and
Figure 3. Colocalization of Pgp and CD44. Double-labeling experiments by LSCM demonstrated that CD44 and Pgp colocalize in some regions of the plasma
membrane of M14 ADR cells. (a) Three-dimensional reconstruction of optically sectioned M14 WT cells labeled with anti-CD44 (red) and anti-Pgp (green).
Adhesion molecule appeared localized all around the cells. (b and c) The analysis of optical sections showed that only a weak signal coming from
intracytoplasmic Pgp was visible (b, yellow arrow). (d) Three-dimensional reconstruction of optical-sectioned double-labeled M14 ADR cells. The analysis of
optical sections showed that the adhesion molecule (green) and the drug transporter (red) colocalized preferentially on ruffles (yellow) of resistant cells
(e, arrowheads). The two molecules were also visible in small vesicles at the cell surface level (f, arrowheads). As observed in sequential optical sections
(g–i), carried out from bottom to the top of the cells, intracytoplasmic yellow spots (arrowheads) were also detected in the proximity of the plasma membrane.
Bar¼10 mm.
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focal contacts (Figure 6d, arrowheads) was observed. Gen-
erally, the great majority of sensitive M14 WT cells adopted
individual cell migration strategies.
On the contrary, M14 ADR cells underwent collective
migration. In fact, it was possible to observe cell clusters
either on the upper (Figure 6e) or lower side of the filter
(Figure 6f), which were characterized by cells closely tied
between each other. In these groups ‘‘leader’’ cells, else-
where named ‘‘guerilla cells,’’ were detected (Friedl et al.,
1997). These cells were very likely highly mobile cells
designated as ‘‘path-generating cells’’ that, at the front of the
body, generate migratory traction via pseudopodal activity
(Friedl et al., 1997; Friedl and Wolf, 2003).
Also during migration through the MatrigelTM, sensitive and
resistant cells seemed to adopt different behaviors: in the case
of sensitive cells, intensely focused proteolytic activity
around invadopodi was noted (Figure 7a–d). Once the
extracellular matrix (ECM) was digested, a phenomenon that
appeared almost completed after 3 hours after seeding (Figure
7a and b), melanoma cells pursued their migration until they
spread out on the substrate (Figure 7c and d). M14 WT cells
recovered their original shape 24 hours after seeding, which
was characterized by a surface covered with randomly
distributed microvilli (Figure 7d). During the invasion
process, M14 WT cells underwent individual migration
adopting a behavior similar to that described in literature as
‘‘mesenchymal’’ migration and similar to the behavior
adopted in absence of MatrigelTM.
Resistant M14 ADR cells maintained their collective
behavior also in the presence of MatrigelTM. In fact, on the
upper side of the filter cell clusters with one or more leader
cells could be observed (Figure 7f, star). Below the filter
(Figure 7e), the ECM degradation was not observed. The
invadopodi of the resistant cells appeared to infiltrate
between the stitches of MatrigelTM in the absence of focused
proteolysis. Invasion without matrix degradation has been
P-gp
CD44
Figure 4. Colocalization of Pgp and CD44 on thin cryosectioned M14 ADR
cells. (a) Sequential labeling of Pgp and CD44 molecules (5 and 10nm gold
particles, respectively) showed that the two molecules were transported from
the synthesis loci to the plasma membrane by different vesicles. (b–d) When
10 and 5 nm gold-positive vesicles were in proximity of the plasma membrane
they began to coalesce: (d, arrow) then, at the surface level complexes of 5
and 10 nm gold particles were frequently observed . Interestingly, vesicles
positive for both Pgp and CD44 were also visible outside the cells (d)
suggesting that the two molecules were released by the cells. Bar¼ 0.1 mm.
90 kDa
170 kDa IB: Pgp
IB: CD44
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Pgp
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Pgp
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CD44
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ADR WT ADR WT ADR WT
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CD44
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Pgp
ADR WT ADR WT ADR WT
Figure 5. Coimmunoprecipitation of Pgp and CD44 molecules.
Coimmunoprecipitation experiments were performed using cell lysates from
sensitive and resistant cells to assess the level of Pgp association with CD44
molecule. (a) mAb to Pgp recognizes a band at 170 kDa in
immunoprecipitates of CD44 obtained from M14 ADR lysates, but not in
those obtained from parental line cells. (b) Anti-CD44 mAb F4 recognizes
a band at 90 kDa in immunoprecipitates of Pgp. Specific control antibodies
immunoprecipitated neither CD44 nor Pgp. (IP Pgp: sample
immunoprecipitated with anti-Pgp MM4.17 antibody; IP CD44: sample
immunoprecipitated with anti-CD44 MC56 antibody; K: sample
immunoprecipitated with isotypic antibodies, such as mouse IgG2a for Pgp
and IgG1 for CD44; IB: immunoblotting with mAb F4, for CD44, and mAb
JSB1, for Pgp).
Table 1. Attachment of M14 WT and M14 ADR cell
lines to extracellular matrix proteins
Substrate M14 WT M14 ADR
Control 742.33772.831 790.32722.94
Hyaluronan 803.007258.20 767.007154.70
Matrigel 976.037107.00 1342.007970
Collagen 1294. 037829.20 1222.117342.70
Fibronectin 2157.237787.20 2910.0071643.50
1Results are expressed as absorbance at 570 nm of stained attached cells.
The data are shown as means7SD for a minimum of three experiments.
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described in the literature as the so-named ‘‘ameboid’’
behavior, which is defined as individual migration strategy.
However, at the end of the migration (Figure 7g), M14 ADR
cells remained adherent to the MatrigelTM as cell clusters.
Role of Pgp in the migration and invasion processes
It was previously observed that CD44 binding by F10-44-2
mAb resulted in increased cell migration and invasion of
human melanoma cells (Takahashi et al., 1999). Thus, to
explore the eventual role of Pgp in the motility and invasion
processes, both M14 WT and M14 ADR cells were treated
with anti-Pgp mAb MM4.17 (10 mg/ml) for 30minutes at
371C, before seeding into the invasion chambers, and in the
absence (Figure 8a and c) or presence of MatrigelTM (Figure 8b
and d). These results were compared with those obtained by
treating cells with anti-CD44 mAb F4 (10 mg/ml) for
30minutes at 371C. By evaluating the percentage of the
occupied area beneath the filters, M14 ADR cells displayed a
migration and invasive potential higher than M14 WT
parental cells. In fact, a slight decrease in the area occupied
by migrating cells was observed after the treatment of M14
WT cells with both anti-Pgp and anti-CD44 mAbs (Figure 8a
and b). On the contrary, a significant increase in the number
of migrating and invading cells was observed after the
treatment of resistant cells with both antibodies, either
administered alone or in combination (Figure 8c and d). In
addition, PD98059 and SB203580 were employed in both
migration and invasion assays. Both inhibitors interfered with
the migration and invasion processes of M14 ADR cells, both
in the absence and presence of anti-CD44 or anti-Pgp mAbs.
After treatment with anti-CD44 mAb (F4) (10 mg/ml) and
anti-Pgp mAb (MM4.17) (10 mg/ml) for 30minutes at 371C,
expression of MMPs at mRNA level was performed on M14
WT and M14 ADR cells. Samples were processed with RT-
PCR and real-time RT-PCR techniques. Treatment with anti-
CD44 mAb induced an increase in the MMP-13 mRNA level
in sensitive cells. In agreement with data obtained by
Takahashi et al. (1999), an increase in MMP-2 and MMP-9
mRNAs was detected in M14 ADR cells treated with anti-
CD44. Noteworthy, the treatment with anti-Pgp induced a
significant increase in MMP-3 and a noticeable decrease in
MMP-13 in resistant cells (Figure 9a). These findings were
confirmed by real-time RT-PCR analysis (Figure 9b).
To verify if the treatment with anti-CD44 and anti-Pgp
mAbs could also interfere with the proteolytic activity of the
cells, the gelatinase activity was studied by collecting the
supernatants of control and treated M14 WT and M14 ADR
cultures. The treatment was performed as described above for
samples utilized in RT-PCR. As shown in Figure 9c, an
increase in proteolytic activity was seen only in MM4.17-
treated M14 ADR cells.
Literature data indicate that cytokines and factors that
activate genes codifying for MMPs follow the way of
mitogen-activated protein kinases (MAPKs; reviewed in
Westermarck and Kahari, 1999). Therefore, the possible
activation of ERK1/2 and p38 MAPKs by Western blotting was
estimated by employing specific antibodies that recognize
the phosphorylated form of the proteins (p-ERK1/2 and p-
p38). The analysis was carried out on M14 WT and M14 ADR
cells before and after the treatment with MM4.17 and F4
mAbs, alone or in association (MM4.17þ F4), and with
relative isotypic immunoglobulins (IgG2a, IgG1), in the
presence or absence of specific inhibitors of protein
phosphorylation (PD98059 for ERK1/2 and SB203580 for
p38 MAPK) (Figure 10a and b). The results demonstrated that
preincubation with anti-Pgp mAb (alone or plus anti-CD44)
induced the activation of ERK1/2 and p38 MAPKs in drug-
resistant M14 ADR cells. By contrast, treatment with the anti-
CD44 F4 mAb alone did not activate ERK1/2 and p38
MAPKs. The presence of PD98059 and SB203580 inhibitors
Filter
Cells
Figure 6. Migration of melanoma cells. SEM observations on drug-sensitive
(M14 WT) and drug-resistant (M14 ADR) cell migration through 8mm pore
membranes employed in the transwell chamber invasion assay. (a and b) Low
magnification of lower side of the membrane, 24 hours after seeding into the
inserts. A higher number of (b) M14 ADR cells could be observed below the
filter when compared with (a) M14 WT cells. The trailing edge of the cell
visible on the (c) upper side of the filter displayed a high concentration of
blebs (arrows). (d) The migrating front was characterized by pseudopodi
(arrow), numerous blebs (double arrowheads), lamellipodi (asterisk), and
focal contacts (arrowhead). (e and f) M14 ADR cells underwent collective
migration. Both on (e) the upper and on (f) the lower side of the filter, cell
clusters, with leader cells (‘‘guerilla cells,’’ asterisk) generating migratory
traction via pseudopodal activity, could be observed. Bars: (a and b) 100 mm;
(c and d) 5 mm; (e) 50mm; (f) 20mm.
962 Journal of Investigative Dermatology (2008), Volume 128
M Colone et al.
Pgp Signaling Promotes Melanoma Cell Invasion
Filter
Matrigel
Cell
Figure 7. Invasion of melanoma cells. SEM observations of (a–d) drug-sensitive (M14 WT) and (e–g) drug-resistant (M14 ADR) cell invasion through
Matrigel
TM
. During invasion through the Matrigel
TM
, sensitive and resistant cells adopted different behaviors. (a–d) Intense focused proteolysis was visible
in sensitive cell samples. (a and b) Cells in the lower side of the filter after 3 hours from the seeding. Invadopodi through the filter pore were visible (arrows).
The extracellular matrix (arrowheads) appeared digested around the cell. (c) After 6 hours seeding, melanoma cells pursued their migration until they spread
out on the lower side of the filter. (d) After 24 hours, M14 WT cells which migrated under the filter recovered their original shape and displayed their surface
covered by randomly distributed microvilli. (e–g) Resistant cells maintained their collective behavior also in the presence of Matrigel. (e) In the lower side
of the filter, the invadopodi of resistant cells appeared to infiltrate between the stitch of Matrigel
TM
in the absence of focused proteolysis. (f) On the upper side
of the filter, cell clusters with one or more ‘‘guerilla cells’’ (asterisks) could be observed. (g) After 24 hours seeding, M14 ADR cells were still adherent
to the matrix as cell clusters. Bars: (a and b) 5 mm; (c and d) 10 mm; (e) 2 mm; (f and g) 20 mm.
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completely abolished ERK1/2 and p38 activation, which was
never observed in M14 WT cells after treatment with
MM4.17 and F4 mAbs (data not shown).
To confirm the role of Pgp in the migration and invasion
processes of resistant melanoma cells, small interference
RNA (siRNA) experiments were performed. Both M14 WT
and M14 ADR cells were silenced for either CD44 or Pgp
expression. The siRNA efficiency was evaluated by measur-
ing Pgp and CD44 protein levels by Western blotting analysis
(Figure 11a). The siRNA-mediated suppression of CD44
mRNA significantly reduced the migration (36%) and
invasion (42%) potential of both M14 WT and M14 ADR
cells. The silencing of the MDR1 gene reduced both
migration and invasion of resistant M14 cells more than
50%, while M14 WT cells that do not express Pgp were
insensitive to the transfection with siRNA as expected.
DISCUSSION
Could Pgp represent a further advantage for the survival and
migration of invasive melanoma cells?
It is assumed that invasive cells must be able to activate
survival mechanisms to prevent induction of apoptosis and to
invade and migrate successfully to distal tissues (Raff, 1992).
Although it is irrefutable that Pgp can efflux xenobiotics out of
the cells, several observations have challenged the notion
that Pgp and related transporter molecules might also play a
fundamental role in regulating cell differentiation, prolifera-
tion, and survival (Johnstone et al., 2000). In particular, Pgp
can confer resistance (by an ATP-independent activity) to a
wide range of caspase-dependent apoptotic stimuli, such as
ligation of cell-surface death receptors, serum starvation, and
UV irradiation (Robinson et al., 1997; Smyth et al., 1998;
Calcabrini et al., 2004; Tainton et al., 2004). Moreover,
several in vitro and in vivo studies indicate that Pgp activity is
often associated with less differentiated and more aggressive
metastasizing tumors, although its role in maintaining this
phenotype remains to be established (Greene et al., 1997;
Witkowski et al., 2000; Liang et al., 2002).
In our previous studies, the alterations associated with the
acquisition of the multidrug-resistant phenotype were in-
vestigated in human melanoma cells. The expression of cell
adhesion molecules was analyzed in a panel of multidrug-
resistant cell lines (M14 Dx) showing different degrees of
resistance to doxorubicin and different levels of Pgp
expression (Molinari et al., 2002). A progressive down-
regulation of CD44 expression on the plasma membrane was
revealed in M14 Dx cells, in parallel with an increasing level
of expression of the drug transporter. Continuous exposure to
doxorubicin induced the selection of cell variants (M14 ADR)
which showed a higher increase of Pgp expression, resistance
to caspase-dependent apoptosis (Calcabrini et al., 2004), and
more aggressive behavior (Molinari et al., 2005). Preliminary
results strongly suggested that the drug transporter Pgp and
the adhesion molecule CD44 might cooperate to confer this
more invasive phenotype in melanoma cells (Molinari et al.,
2005). It is worth mentioning that recent literature has
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reported that there is a close interaction between CD44 and
Pgp that results in the concurrent expression and modulation
of two malignant phenotypes, invasion, and MDR in human
breast and ovarian carcinoma cell lines (Miletti-Gonza´lez
et al., 2005).
It has been previously demonstrated that the cytoplasmic
tail region of CD44 can be linked to ERM proteins. These
proteins play the dual role of anchoring CD44 to the
intracellular actin skeleton and regulating the assembly,
mediated by CD44, of the intracellular complexes that are
important in signal transduction (Ponta et al., 2003). More-
over, a clear association between Pgp and actin skeleton
through ERM proteins and a significant inhibition of Pgp-
mediated MDR after specific inhibition of ERM synthesis
were reported (Luciani et al., 2002). In this study, the
association of Pgp with ERM proteins was confirmed in M14
ADR cells by double-labeling experiments in LSCM analysis
(data not shown). Moreover, according to Bacso et al. (2004)
and Miletti-Gonza´lez et al. (2005), the hypothesis of
molecular vicinity and physical interaction of Pgp and
CD44 molecules appears to be corroborated by LSCM
observations on double-labeled M14 ADR cells and by
coimmunoprecipitation experiments. In particular, the former
showed that Pgp and CD44 colocalized on ruffles of the
plasma membrane of drug-resistant melanoma cells. Ruffles
were defined as distinct compartments enriched in filamin
and ezrin (Borm et al., 2005). Remarkably, drugs transported
by Pgp induce membrane ruffling, an early indicator of
cellular motility and metastatic potential, in Pgp overexpres-
sing cancer cells and this effect may be mediated through
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activation of phosphatidylinositol 3-kinase (Yang et al.,
2002). However, Pgp and CD44 display a ‘‘conjoint destiny’’
during the trip toward the plasma membrane mediated by the
same shuttle vesicles that transport the two molecules to the
surface of the cells.
According to our previous study (Molinari et al., 2005), the
in vitro migration and invasion potential of drug-resistant
M14 ADR cells, overexpressing the MDR1 transporter,
appeared to be higher than that of sensitive M14 WT cells,
as demonstrated by the in vitro ‘‘transwell chamber invasion’’
assay (Molinari et al., 2005). The study performed by SEM
demonstrated that M14 WT parental cells preferentially
migrated individually and employed focused matrix degrada-
tion to pass through the MatrigelTM film: the migration
behavior which is described in the literature as ‘‘mesenchy-
mal migration’’ (reviewed in Friedl and Wolf, 2003). Focused
proteolysis is mainly due to the activity of proteases, strongly
concentrated in the proximity of integrin binding to ECM.
Proteases cut collagen, fibronectin laminin, and pro-MMPs to
create active soluble MMPs like MMP-2. MT1-MMP, MMP1,
and other collagenases cut native collagens, or other ECM
molecules, in smaller fragments accessible to the subsequent
degradation of the gelatinases (MMP-2 and MMP-9) (Der-
yugina et al., 1998). M14 ADR cells did not show focused
matrix degradation during the penetration into the MatrigelTM
film. The invasion in the absence of proteolytic activity has
been described in the literature as ‘‘ameboid’’ migration
(reviewed in Friedl and Wolf, 2003). Such a shape-driven
migration allows cells to circumnavigate, rather than
degrade, their ECM barriers, allowing them to move at 10-
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to 30-fold higher velocities than cells that use mesenchymal
migration mechanisms (Friedl and Wolf, 2003). Moreover,
M14 ADR cells preferentially migrated as cluster cells.
Previous studies described melanomas that migrate in a
collective movement where cells ‘‘stream’’ one after another
in a strand-like fashion. When clusters of melanoma cells
were implanted into three-dimensional fibrillar collagen, cell
‘‘strands’’ developed within matrix defects. The strand was
generated by the first invading cell, or the ‘‘guerilla cells’’
(Friedl et al., 1997). It has been assumed that collective
migration can represent a favorable strategy for tumor cells.
The arrangement of invading tumor cells in chains seems to
represent a particularly effective penetration mechanism that
confers high metastatic capacity and poor prognosis.
In which manner do the molecular vicinity and the
physical interaction of Pgp and CD44 on the plasma
membrane contribute to the higher malignancy of drug
resistant melanoma cells? Experiments performed by employ-
ing specific mAbs directed against CD44 and Pgp strongly
induced a significant increase of both the migration and
invasive potential of Pgp-positive drug-resistant cells. It was
previously observed that the CD44 binding by F10-44-2 mAb
resulted in induction of MMP-2 secretion and MMP-2 mRNA
expression, associated with enhanced cell migration and
invasion of human melanoma cells (Takahashi et al., 1999).
The authors suggest the potential existence of a CD44-
mediated signal transduction pathway that upregulates
MMP-2 production and that is associated with enhanced
melanoma-cell migration and invasion. In our study, the
treatment with both anti-CD44 and anti-Pgp mAbs only
affected the migration and invasive potential of resistant Pgp/
CD44-positive M14 ADR cells, leading to a more aggressive
phenotype.
The real-time RT-PCR analysis of MMPs demonstrated the
increase in M14 ADR cells, but not in M14 WT cells, of
MMP-2 and MMP-9 mRNAs induced by F4. In spite of the
lower invasion potential of sensitive cells, when compared to
that of the resistant ones, the basal level of MMP-2 mRNA
appeared to be higher in drug-sensitive than in drug-resistant
cells. On the other hand, endogenous gelatinase activity
appeared to be strongly stimulated in drug-resistant cells,
especially after treatment with anti-Pgp mAb. In addition, the
stimulation with MM4.17 mAb increased noticeably MMP-3
mRNA. It has been reported that MMP-3 can activate other
pro-MMPs including pro-MMP-1, pro-MMP-8, pro-MMP-9,
and pro-MMP-13 (Murphy et al., 1987; Ogata et al., 1992;
Knauper et al., 1993, 1996). MMP gene expression is
primarily regulated at the transcriptional level, but there is
also evidence of modulation of mRNA stability in response to
growth factors and cytokines (reviewed in Westermarck and
Kahari, 1999). The expression of inducible MMP genes
(MMP-3, MMP-9, and MMP-13) is stimulated by growth
factors, cytokines, and other environmental factors. A major
difference between MMP-2 and MMP-9 is their differential
regulation of expression. These differences can be traced to
the promoter elements of the gelatinases. The promoter of
MMP-9 is similar to most other MMPs, whereas MMP-2
promoter lacks many of the inducible promoter elements
such as binding sites for the activating protein-1 and E26
transformation-specific transcription factors regulated by
MAPKs (reviewed in Bjorklund and Koivunen, 2005).
Cytokines and growth factors that activate MMP-3, MMP-9,
and MMP-13 expression typically act via the MAPK pathway,
which includes the ERK1/2, JNK/SAPK 1/2, and p38 proteins
(reviewed in Westermarck and Kahari, 1999).
Previous data demonstrated that overexpression of the
MDR1 gene was associated with a constitutive activation of
the ERK/MAPK pathway and phosphatidylinositol 3-kinase
activities (Ding et al., 2001). How MDR1 results in the
activation of these pathways is unclear and may identify
novel functions for Pgp. In this study, we found that a clear
activation of ERK1/2 and p38 MAPKs was induced after
treatment with mAb anti-Pgp alone or in association with
anti-CD44 in M14 ADR cells. Similarly, b-TGF treatment
rapidly activated ERK1/2 and p38 MAPKs leading to
upregulation of MMP-2 and MMP-9 with the increase of
the invasive ability of MCF10A human breast epithelial cells
(Kim et al., 2004). In addition, p38 MAPK phosphorylation
upregulates the MAPK pathway leading to the stability of
MMP-1 and MMP-3 mRNAs (Reunanen et al., 2002).
Moreover, ERK activation is likely to impact invasion and
migration through many pathways by influencing gene
transcription (AP-1 factor) and survival, as well as by directly
regulating the enzymes (MLCK) that are necessary for cell
locomotion (Hood and Cheresh, 2002). On the other hand,
the absence of induction of MAPK signaling by mAb anti-
CD44 alone could indicate that migration and invasion
stimulated by mAb F4 take different pathways (e.g., Rac1/
PKN kinase) as demonstrated elsewhere (Bourguignon et al.,
2007).
Finally, siRNA experiments further demonstrated the
involvement of the MDR1 transporter in both migration and
invasion processes of melanoma cells. Modulation of MDR
by transfection of synthetic siRNAs has been reported
recently (Nieth et al., 2003; Wu et al., 2003). However,
complete reversal to the drug-sensitive phenotype of parental
cells has not been obtained in any study. This is probably due
to two reasons. First, the transfection of synthetic siRNAs
causes only transient suppression of target genes. Second,
Pgp has a long life time (Muller et al., 1995). These data,
paralleled by the significant but not complete suppression of
Pgp expression obtained in our experimental conditions,
could explain the inhibition of only 50% of the migration of
the M14 ADR cells.
In conclusion, in our experimental model, the MDR
molecule interacts with CD44 through the activation of the
ERK1/2 and p38 MAPK pathways. This leads to an increase of
the invasive behavior, associated with an increase in MMP
mRNAs (MMP-2, MMP-3, and MMP-9) and proteolytic
activity. Two specific signals originated from CD44 and
Pgp: one from CD44 that led to the increase of gelatinases
MMP-2 and MMP-9 mRNAs; the other from Pgp leading to
the increase of MMP-3 mRNA. Interestingly, in the absence of
Pgp, CD44 did not interfere with cell migration and invasion.
On the contrary, the presence of Pgp proved to be mandatory
both for the induction of cell migration and, overall, for the
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induction of ERK1/2 and p38 MAPK signaling. Finally,
unlike drug-sensitive (Pgp-negative) melanoma cells, which
showed an ‘‘individual mesenchymal’’ behavior, Pgp
overexpressing melanoma cells adopted a ‘‘chain collective’’
migration strategy reflecting potential high metastatic
capacity.
MATERIALS AND METHODS
Cell cultures
The established human melanoma cell line (M14 WT) and its
derivative MDR variant (M14 ADR) were grown in RPMI 1640
medium (Flow Laboratories, Irvine, UK) supplemented with 1%
nonessential amino acids, 1% L-glutamine, 100 IU/ml penicillin,
100 IU/ml streptomycin, and 10% fetal calf serum (Flow Labora-
tories) at 371C in a 5% CO2 humidified atmosphere in air. The M14
ADR cell line was selected culturing M14 cells in the presence of
40 mM ADR (Adriblastina; Pharmacia & Upjohn S.p.A, Milan, Italy) as
described in Calcabrini et al. (2004).
Reagents
mAbs anti-Pgp C219 and JSB1 were obtained from Signet
Laboratories, Inc. (Dedham, MA) and used at a dilution of 1:20 for
immunofluorescence and 1:1,000 for Western blotting. mAb
MM4.17, an IgG2ak monoclonal immunoglobulin reacting with a
distinct human-specific epitope of the extracellular domain of the
MDR1-Pgp isoform, was provided by Dr Cianfriglia (Cianfriglia
et al., 1994) and used at a dilution of 1:50 for immunofluorescence
and 1:1,000 for Western blotting studies. mAb anti-CD44 MC56 was
provided by Dr Cianfriglia (Cianfriglia et al., 1992) and used diluted
1:20 for immunoprecipitation experiments. mAbs HCAM (F4)
(dilution 1:50 for immunofluorescence and 1:1,000 for Western
blotting), anti-phospho-p38 MAPK (p-p38/D8, 1:1,000), anti-p38
(1:1,000), and polyclonal antibody anti-ERK2 (C14, 1:2,000) were
obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Polyclonal antibody anti-phospho-p44/42 MAPK (Thr202/Tyr204)
(p-ERK1/2, 1:1,000), SB203580, and PD98059 inhibitors were from
Cell Signaling Technology (Beverly, MA). mAb anti-a-tubulin
(1:10,000), control mouse isotypic immunoglobulins (1:20), rhoda-
mine-linked rabbit anti-mouse IgG (1:50), and fluorescein-linked
goat anti-mouse IgG antibodies (1:50) were purchased from Sigma
Chemical Company (St Louis, MO).
LSCM
For the analysis of Pgp and CD44 expression, cells grown
on coverslips were incubated with MM4.17 or HCAM-F4 mAbs
for 10minutes at 41C. After being washed in phosphate-buffered
saline (PBS) buffer, supplemented with 0.5% BSA (PBS-BSA),
samples were incubated with fluorescein-linked goat anti-mouse
IgG antibody for 30minutes at 41C. After being washed, cells were
fixed for 5minutes with 2% paraformaldehyde in PBS. Negative
controls were obtained by incubating the samples with mouse IgG2a
isotypic globulins.
For the colocalization of Pgp and CD44 proteins, sequential
double immunolabeling was performed. Cells were first fixed and
permeabilized with cold methanol for 10minutes. Then cells were
labeled for Pgp with MM4.17 mAb for 10minutes at 41C. After being
washed in PBS-BSA buffer, samples were incubated with rhodamine-
linked rabbit anti-mouse IgG for 30minutes at 41C. After being
washed, cells were fixed with 0.1% glutaraldehyde, preincubated
with glycine (0.15M in PBS), and then labeled with HCAM-F4 mAb
and fluorescein-linked goat anti-mouse IgG antibody. After being
washed in PBS-BSA, samples were mounted in PBS/glycerol (1:2)
and observed with a Leica TCS SP2 laser scanning confocal
microscope (Leica Microsystems, Mannheim, Germany). The excita-
tion and emission wavelengths used were 488 and 543nm for
fluorescein and rhodamine, respectively. Observations were per-
formed in sequential double fluorescence mode and fluorescence
emissions were collected after passage through a DD 488/543 filter.
The images are the results of optical sectioning and three-
dimensional max projection reconstruction.
Invasion assays and motility assays
Invasion assays were performed by a modification of the method
described by Albini et al. (1987). Inserts (8.0 mm pore) (BD
Biosciences, Erembodegem, Belgium) which stood in six-well Costar
plates (Corning Inc., Corning, NY) were employed. MatrigelTM
(Sigma) was diluted to 1mg/ml in serum-free RPMI medium.
100ml of 1mg/ml MatrigelTM solution was placed on the lower side
of each insert. The insert and the plate were incubated overnight at
41C. The following day, cells were harvested and suspended in RPMI
at a concentration of 1 106 cells/ml. The inserts were washed with
serum-free RPMI, then 1 106 cells was added to each insert, and
3ml of RPMI containing 10% fetal calf serum was added to the well
underneath the insert. Cells were incubated at 371C for up to
24 hours. After this time, the inner side of the insert was wiped with a
wet swab to remove the cells while the outer side of the insert was
gently rinsed with PBS and stained with 0.25% crystal violet (Sigma)
for 10minutes, rinsed again, and then allowed to dry. The inserts
were then viewed under a CCD camera equipped Nikon (Tokyo,
Japan) Optiphot microscope and the percent of area occupied by
migrated cells was analyzed by Optilab software (Graftek Mirmande,
France). The procedure for carrying out motility assay was identical
to the procedure used for invasion assays with the exception that
inserts were not coated with MatrigelTM. For the assay in the presence
of anti-Pgp and anti-CD44 mAbs, before the seeding into the inserts,
cells were incubated with MM4.17 (10mg/ml) and F4 (10 mg/ml)
mAbs for 30minutes at 371C.
SEM
For SEM analysis, the membranes with 8.0 mm pores with migrated
cells were removed from the inserts. At the indicated times,
membranes were fixed with 2% glutaraldehyde in 0.1 M cacodylate
buffer (pH 7.4) at room temperature for 30minutes, postfixed with
1% OsO4 in the same buffer, dehydrated through a graded ethanol
series, critical point dried with CO2, and gold coated by sputtering.
Samples were examined with a Cambridge Stereoscan 360 scanning
electron microscope (Cambridge Instruments Ltd, Cambridge, UK).
RT-PCR analysis
Total cellular RNA was prepared from PBS-washed cells using the
TRIzols Reagent (Gibco BRLs, Life Technologies, Gaithersburg,
MA) according to the manufacturer’s instructions. The quantity and
purity of RNA were estimated spectrophotometrically and their
integrity was checked by electrophoresis on 1% agarose gel.
RT was carried out with 1mg of total cellular RNA from each
sample using the Qiagen OneStep RT-PCR Kit (Qiagen GmbH,
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Hilden, Germany). The mRNAs investigated included those coding
for MMP-2, MMP-3, MMP-9, MMP-13, MMP-14, and b-actin.
The primer sequences are the following:
MMP-2 bp 580:
50-GTGCTGAAGGACACACTAAaGAAGA-30 sense,
50-TTGCCATCCTCCTCAAAGTTGTAGG-30 antisense;
MMP-3 bp 515:
50-AGATGCTGTTGATTCTGCTGTTGAG-30 sense,
50-ACAGCATCAAAGGACAAAGCAGGAT-30 antisense;
MMP-9 bp 243:
50-CACTGTCCACCCCTCAGAGC-30 sense,
50-GCCACTTGTCGGCGATAAGG-30 antisense;
MMP-13 bp 330:
50-GTGGTGTGGGAAGTATCATCA-30 sense,
50-GCATCTGGAGTAACCGTATTG-30 antisense;
MMP-14 bp 497:
50-CGCTACGCCATCCAGGGTCTCAAA-30 sense,
50-CGGTCATCATCGGGCAGCACAAAA-30 antisense;
b-actin bp 450:
50-TCTGGCCGTACCACTGGCAT-30 sense,
50-CACTGTGTTGGCGTACAGGT-30 antisense.
Amplification of b-actin was used as the endogenous control for
all reactions undertaken to monitor the quality of the RNA
extraction. Briefly, target fragments were amplified under the
following conditions: RT step of 30minutes at 501C; initial PCR
activation step of 15minutes at 951C; 35 cycles of 1minute at 951C,
40 seconds at 601C, and 1minute at 721C; and a final extension step
of 10minutes at 721C and quick chill to 41C in a 9600 thermocycler
(Perkin Elmer Cetus, Emeryville, CA). The amplification product
(5ml) was visualized in 2% agarose in Tris-acetate-EDTA (TAE) gel by
ethidium bromide staining and UV transillumination.
Quantitative real-time RT-PCR
An aliquot (100 ng) of the RNA preparation from untreated and
treated samples was used for quantitative real-time RT-PCR (qrt-RT-
PCR). One-step qrt-RT-PCR was conducted using the QuantiTect
SYBER green RT-PCR kit (Qiagen GmbH, Hieden, Germany).
The relative reaction mixtures and the amplification procedures
were carried out according to the manufacturer’s guidelines for the
LightCycler instrument in a final volume of 20 ml.
To prevent carryover contamination, an aerosol-resistant tip was
used in all steps and the preparation of the PCR mixture
was performed in a separate area. All reactions were performed
in triplicate, and independent PCRs were performed using the
same RNA for both the gene of interest and the b-actin. For
each gene, the same primer pair sets described above were
used. The PCR conditions consisted of one cycle at 501C for
30minutes; one cycle at 951C for 15minutes; 45 cycles at 951C
for 5 seconds, 531C for 13 seconds, and 601C for 15 seconds with
the ramp of 201C/s for each cycle. The change in fluorescence of
SYBER green dye in every cycle was monitored by the system
software, and the threshold cycle (CT) above the background
for each reaction was calculated.
The difference between the fluorescence CT for the target gene
and the endogenous control (b-actin mRNA) is presented as a DCT
value (CT of target – CT of control). For reference, a DCT of 2 is
approximately equivalent to a 4-fold change in the amount of the
transcript.
Coimmunoprecipitation
M14 WT and M14 ADR cells were lysed in cold lysis NTENT buffer
(150mM NaCl, 10mM Tris–HCl, pH 7.2, 1mM EDTA, and 0.1mM
phenylmethylsulfonyl fluoride containing complete mini proteinase
inhibitors (Roche Applied Science, Monza, Italy)), immunoprecipi-
tated from lysate with anti-Pgp (C219þ JSB1) and anti-CD44 (MC56)
antibodies, respectively, 1 hour at 41C in the presence of protein
AþG plus agarose (Santa Cruz Biotechnology). As a control, mouse
IgG2a isotypic antibody was employed. Immunoprecipitated beads
were washed four times in NTENT buffer, resuspended in Laemmli
sample buffer supplemented with 2-mercaptoethanol, boiled for
5minutes, and resolved in 8% SDS-PAGE. Immunoprecipitated
proteins were transferred electrophoretically onto nitrocellulose
(Trans-blots; Bio-Rad Laboratories Inc., Hercules, CA) using a
semi-dry blotting system (C.B.S. Scientific Company Inc., Del Mar,
CA). The nitrocellulose membrane was blocked with 5% nonfat milk
in TTBS (20mmol/l Tris–HCl buffer, 9 g/l NaCl, and 1ml/l Tween 20)
for 1 hour at room temperature, and then incubated overnight at 41C
in primary antibody to anti-MDR1 (clone JSB1 diluted 1:1,000) and
anti-CD44 (HCAM, clone F4, diluted 1:1,000). After being washed
with TTBS, the membrane was incubated for 1 hour at room
temperature with blotting grade affinity-purified goat anti-mouse
(IgG Hþ L) horseradish peroxidase conjugate (Bio-Rad Laboratories).
Immunoreactive bands were visualized with enhanced chemilumine-
scence (ECL, Santa Cruz Biotechnology). For loading control,
membranes were incubated with monoclonal anti-a-tubulin.
Western blotting
To study Pgp and CD44 expression in M14 WT and M14 ADR, cells
(3 106 cells/dish) were washed twice in ice-cold Tris-buffered
saline (TBS; 20mM Tris–HCl, pH 7.6, 140mM NaCl) and lysed at 41C
in 200 ml of lysis buffer (10mM Tris–HCl, pH 7.6, 50mM NaCl, 30mM
sodium pyrophosphate, 5mM EDTA, 0.5% Nonidet P40, 1% Triton
X-100, 50mM NaF, 0.1mM Na3VO4, 1mM phenylmethylsulfonyl
fluoride, and complete mini proteinase inhibitors). Cell lysates were
obtained by centrifugation at 17,000 g for 30minutes at 41C;
protein concentration in the supernatant was determined by DC
Protein Assay (Bio-Rad Laboratories), and lysates were adjusted to
equivalent concentrations with lysis buffer. Total cell lysate
(10–40 mg) was then separated on SDS-PAGE. Proteins were
transferred to polyvinylidene difluoride membranes that were
blocked for 1 hour at room temperature with 5% nonfat milk in
TTBS. Incubations with primary specific antibodies (JSB1 for Pgp and
HCAM for CD44) and with horseradish peroxidase-conjugated
secondary antibodies were performed in blocking solution overnight
at 41C and for 1 hour at room temperature, respectively. Immuno-
reactive bands were visualized by the ECL kit. For loading control,
membranes were incubated with monoclonal anti-a-tubulin.
For ERK1/2 and p38 activation studies, M14 WT and M14 ADR
cells (3 106 cells/sample) were stimulated for 30minutes with
MM4.17 or HCAM-F4 mAbs or both (10 mg/ml). For inhibition of
protein phosphorylation, before incubation with MM4.17 or HCAM-
F4 mAbs, samples were pretreated for 2 hours with the known
inhibitors of ERK1/2 and p38 activation (10 mM PD98059 and
SB203580, respectively).
Samples were then lysed as described above. Membranes were
incubated with primary (anti-p-ERK1/2 and anti-phospho-p38
MAPK) and with secondary antibodies as described previously.
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To assess loading control, membrane stripping was performed
incubating for 30minutes at 651C in 62.5mM Tris–HCl (pH 6.8)
containing 2% SDS and 100mM 2-mercaptoethanol, and extensively
washed with TTBS at room temperature. Membranes were subse-
quently blocked and incubated with anti-ERK2 and p-38 antibodies.
Cryosections
For ultrathin cryosections, cells were fixed with 4% paraforma-
ldehyde plus 0.1% glutaraldehyde in PBS (pH 7.4) for 2 hours at
room temperature, washed, and embedded in 2% agarose low
melting point that was solidified on ice. Agarose blocks were infused
with 2.3 M sucrose in PBS overnight at 41C, frozen in LN2, and
cryosectioned following the method of Tokuyasu (1973) using the
Ultracut UCT device (Leica Microsystems, Wien, Austria). Ultrathin
cryosections were collected using sucrose and methylcellulose and
incubated with specific mAb, then revealed with protein A-gold
conjugates of different sizes (5 or 10 nm, as appropriate) (1:10
diluted; Sigma-Aldrich, Milan, Italy). Finally, ultrathin cryosections
were stained with solutions of 2% methylcellulose and 0.4% uranyl
acetate before electron microscopy examination. Observations were
performed using the Philips 208 transmission electron microscope
(FEI Company, Eindhoven, The Netherlands).
MMP gelatinase activity assay
For the analysis of the endogenous and induced gelatinase activity,
both M14WT and M14 ADR cells (1 106) were treated with 10mg/ml
anti-CD44 mAb (F4) or anti-Pgp mAb (MM4.17) for 30minutes at
371C. Cells were then plated and allowed to grow for 24 hours at
371C in a humidified atmosphere, in the presence of 5% CO2. Then
the medium of cultures was analyzed for proteolytic activity. MMP
activity was measured using the chromogenic MMP-2 and MMP-9
activity assays CHEMICONs MMP Gelatinase Activity Assay Kit
(Chemicon International Inc., Temecula, CA), according to the
manufacturer’s protocol. These assays utilize a biotinylated gelati-
nase substrate, which is cleaved by active MMP-2 and MMP-9
(gelatinase) enzymes. Remaining biotinylated fragments are then
added to a biotin-binding 96-well plate and detected with
streptavidin-enzyme complex. Addition of enzyme substrate results
in a colored product, detectable by its optical density (OD) at
450 nm. If MMP activity is present, a low signal will result (less color)
due to MMP cleavage of the biotinylated-gelatin and the lack of
biotin-binding sites. OD values of samples treated with mAbs were
compared with OD values obtained by relative control cultures
{(untreated cultures OD/mAb-treated cultures OD) 100¼ percent
activity}. Results represent mean values of three independent
experiments7SD.
RNA interference
M14 WT and M14 ADR cells (2 105/well) were seeded onto
six-well plates 24 hours before transfection in RPMI 1640 antibiotic
free (2ml) and then transfected with control siRNA, HCAM siRNA,
and MDR1 siRNA (Santa Cruz Biotechnology) by using Lipofecta-
mine 2000 (Invitrogen, S.R.L. San Giuliano, Milanese, Italy)
according to the manufacturer’s protocol. For cell extract prepara-
tion, the cells were washed with ice-cold PBS/BSA and centrifuged
for 30minutes at 41C in Nonidet P40 lysis buffer (40mM Tris, 1%
Nonidet P40, 1mM Na3VO4, 1mM NaF, 1mM phenylmethylsulfonyl
fluoride, and protease inhibitor cocktail). Equal amounts of cell
proteins were separated by SDS-PAGE, then electrotransferred to
nitrocellulose and incubated with specific anti-HCAM (Santa Cruz
Biotechnology) and anti-C219 (Signet, Covance Research Products
Inc, Denver, PA) mAbs. Enhanced chemiluminescence (ECL,
Amersham Biosciences, Piscataway, NJ) was used for detection.
Statistical analysis
Reported values are the means7SD from three independent
experiments. Statistical analyses were performed using Mann–Whitney
U-test. A P-value lower than 0.05 was considered significant.
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